Executive turmoil resurfaced at Abbey Health Group last week as the company's board of directors flip-flopped on the status of its president, Jerilyn Asher.
The controversy began Dec. 14 when Abbey released a brief statement saying that it had asked Ms. Asher to step down as president of the Costa Mesa, Calif.-based home-care company and take a leave of absence.
"She had some personal problems and illnesses in the family," Abbey spokeswoman Susan Turkell said on Dec. 14. She declined to elaborate.
Abbey didn't say whether Ms. Asher would return to her duties at a later date, nor did it say whether Ms. Asher had agreed to step down from her position.
A day later, Abbey issued a second statement withdrawing its initial request, "pending further discussions between the company and Ms. Asher."
Ms. Turkell said the second statement was released in part to clarify that Ms. Asher was not dismissed as president.
Ms. Turkell said she was unable to provide additional information, and Ms. Asher couldn't be reached for comment.
The uncertainty surrounding Ms. Asher is the latest in a series of internal conflicts at Abbey.
Ms. Asher, 44, was named president of Abbey in June, shortly after the company completed its $12 million cash purchase of Protocare, a Waltham, Mass.-based home infusion company. She replaced Abbey's previous head of operations, Victor Chaltiel, who was ousted by Abbey Chairman Timothy Aitken in February after serving less than four months as president and CEO.